322
Views
10
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Identification of peptides present in sour milk whey that ameliorate scopolamine-induced memory impairment in mice

, , &
Pages 33-45 | Received 14 Dec 2016, Accepted 21 Apr 2017, Published online: 23 May 2017

References

  • Buccafusco JJ. 2009. The revival of scopolamine reversal for the assessment of cognition-enhancing drugs. In: Buccafusco JJ, editor. Methods of behavior analysis in neuroscience. 2nd ed. Boca Raton (FL): CRC Press/Taylor & Francis; Chapter 17.
  • Camfield DA, Owen L, Scholey AB, Pipingas A, Stough C. 2011. Dairy constituents and neurocognitive health in ageing. Br J Nutr. 106:159–174.
  • Crichton GE, Murphy KJ, Bryan J. 2010. Dairy intake and cognitive health in middle-aged South Australians. Asia Pac J Clin Nutr. 19:161–171.
  • Crichton GE, Elias MF, Dore GA, Robbins MA. 2012. Relation between dairy food intake and cognitive function: The Maine-Syracuse longitudinal study. Int Dairy J. 22:15–23.
  • Espallergues J, Lapalud P, Christopoulos A, Avlani VA, Sexton PM, Vamvakides A, Maurice T. 2007. Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. Br J Pharmacol. 152:267–279.
  • Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. 2008. Efficacy and safety of donepezil, galantamine and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis. Clin Interv Aging. 3:211–225.
  • Holzer P, Reichmann F, Farzi A. 2012. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 46:261–274.
  • Itoh J, Ukai M, Kameyama T. 1993. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur J Pharmacol. 236:341–345.
  • Kanda Y. 2013. Investigation of the freely-available easy-to-use software “EZR” (Easy R) for medical statistics. Bone Marrow Transplant. 48:452–458.
  • Kang Y, Lee W, Kang B, Kang H. 2013. Memory-enhancing effects of silk fibroin-derived peptides in scopolamine-treated mice. J Microbiol Biotechnol. 23:1779–1784.
  • Kim MJ, Yoon BH, Kim YW, Lee S, Shin BY, Jung JW, Kim HJ, Lee YS, Choi JS, Kim SY, et al. 2007. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J Pharmacol Sci. 105:82–93.
  • Klinkenberg I, Blockland A. 2010. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev. 34:1307–1350.
  • Kokkinidis L, Anisman H. 1976. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task. Psychopharmacology (Berl). 48:261–270.
  • Morley JE, Armbrecht HJ, Farr SA, Kumar VB. 2012. The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. Biochim Biophys Acta. 1822:650–656.
  • Myhrer T. 2003. Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Rev. 41:268–287.
  • Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. 1995. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci. 78:777–783.
  • Ohsawa K, Uchida N, Ohki K, Nakamura Y, Yokogoshi H. 2015. Lactobacillus helveticus-fermented milk improves learning and memory in mice. Nutr Neurosci. 18:232–240.
  • Ozawa M, Ohara T, Ninomiya T, Hata J, Yoshida D, Mukai N, Nagata M, Uchida K, Shirota T, Kitazono T, Kiyohara Y, et al. 2014. Milk and dairy consumption and risk of dementia in an elderly Japanese population: the Hisayama study. J Am Geriatr Soc. 62:1224–1230.
  • Picariello G, Ferranti P, Fierro O, Mamone G, Caira S, Si Luccia A, Addeo F. 2010. Peptides surviving the simulated gastrointestinal digestion of milk proteins: biological and toxicological implications. J Chromatogr B Analyt Technol Biomed Life Sci. 878:295–308.
  • Roberts PR, Burney JD, Black KW, Zaloga GP. 1999. Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion. 60:332–337.
  • Sakaguchi M, Koseki M, Wakamatsu M, Matsumura E. 2006. Effects of systemic administration of beta-casomorphin-5 on learning and memory in mice . Eur J Pharmacol. 530:81–87.
  • Sarter M, Bodewitz G, Stephens DN. 1988. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and antagonist β-carbolines. Psychopharmacology (Berl). 94:491–495.
  • Shin BY, Lee HY, Kim D, Park CS, Lee Y, Cho HJ, Kim DH, Yamamoto Y, Kang DH, Lee S, et al. 2009. Ameliorating effect of a herbal medicinal prescription Kyung-Ok-Ko, on scopolamine-induced memory impairment in mice. J Trad Med. 26:35–43.
  • Skibicka KP, Dickson SL. 2013. Enteroendocrine hormones – central effects on behavior. Curr Opin Pharmacol. 13:977–982.
  • Stone WS, Walser B, Gold SD, Gold BE. 1991. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav Neurosci. 105:264–271.
  • Sugimoto H, Ogura H, Arai Y, Limura Y, Yamanishi Y. 2002. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol. 89:7–20.
  • Takenaka Y, Nakamura F, Jinsmaa Y, Lipkowski AW, Yoshikawa M. 2001. Enterostatin (VPDPR) has anti-analgesic and anti-amnesic activities. Biosci Biotechnol Biochem. 65:236–238.
  • Van Dam D, De Deyn PP. 2006. Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discov. 5:956–970.
  • van der Pijl PC, Kies AK, Ten Have GA, Duchateau GS, Deutz NE. 2008. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides. 29:2196–2202.
  • Walf AA, Frye CA. 2007. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2:322–328.
  • Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. 2014. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet. 5:88.
  • Yamazaki M, Okabe M, Yamamoto N, Yarimizu J, Harada K. 2015. Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats. J Pharmacol Sci. 127:362–369.
  • Yang JH, Han SJ, Ryu JH, Jang IS, Kim DH. 2009. Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice. Biol Pharm Bull. 32:1710–1715.
  • Zhao L, Huang Q, Huang S, Lin J, Wang S, Huang Y, Hong J, Rao P. 2014. Novel peptide with a specific calcium-binding capacity from whey protein hydrolysate and the possible chelating mode. J Agric Food Chem. 62:10274–10282.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.